Opiatech
Paris, FR · 1 known investors
Find your way into Opiatech
Sign up to see every warm intro you have to Opiatech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Opiatech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OPIA Technologies develops ophthalmic medical devices for diagnosing and treating ocular diseases, including tools for sampling ocular surface components (conjunctiva, tear film) and non-invasive ocular drug delivery based on proprietary patents. The company covers the full device life cycle — design, manufacturing, and regulatory/quality compliance — and also offers R&D and regulatory services to other medical device companies.
Investors · 1
Frequently asked questions
- What does Opiatech do?
- OPIA Technologies develops ophthalmic medical devices for diagnosing and treating ocular diseases, including tools for sampling ocular surface components (conjunctiva, tear film) and non-invasive ocular drug delivery based on proprietary patents. The company covers the full device life cycle — design, manufacturing, and regulatory/quality compliance — and also offers R&D and regulatory services to other medical device companies.
- Who are Opiatech's investors?
- Opiatech's investors include Agoranov.
- Where is Opiatech headquartered?
- Opiatech is headquartered in Paris, FR.
